Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 02 source : Www.poseida.com save search
P-PSMA-101 is a High-Tscm Autologous CAR-T Targeting PSMA Producing Exceptionally Deep and Durable Responses in Castration-Resistant Metastatic Prostate Cancer (mCRPC)
Published: 2021-09-02 (Crawled : 16:00) - poseida.com
PSTX | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: 3.27%
H: 0.0%
C: -4.98%
prostate cancer car-t cancer
Developing piggyBac Systems “Off-the-Shelf” CAR-T Cells for Bone Marrow Transplant Conditioning
Published: 2021-09-02 (Crawled : 13:00) - poseida.com
PSTX | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: 3.27%
H: 0.0%
C: -4.98%
bone car-t t-cell
Poseida’s CAR-T Cell Therapy for Prostate Cancer Shows Promising Durable Response in Phase 1
Published: 2021-09-02 (Crawled : 01:00) - poseida.com
PSTX | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: 3.27%
H: 0.0%
C: -4.98%
prostate cancer phase 1 therapy car-t cancer phase 2 phase 3 response t-cell
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
MUSA 4 | $417.23 1.06% 0.01% 170K
|
Retail Trade
JBI 4 | $15.14 1.34% 0.0% 2.9M
|
SBS | $15.49 -1.59% -0.84% 4.6M
|
Utilities
ARCO | $10.9 1.3% -3.39% 1.1M
|
Consumer Services
NOV 4 | $18.75 1.35% -6.67% 3.2M
|
Industrial Services
Your saved searches
Save your searches and get alerts when important news are released.